Skip to content

EAS-MED

Active Private limited companyfounded 2019active for 6 yearsCommandant Vander Meerenlaan 9, 1070 AnderlechtKBO/BCE: BE 0738.882.454

Lifetime

6 annual accounts with figures on one time axis
peak of €87,805 in 2021
€85,877▲ 380%
peak of €50,993 in 2026
€50,993▲ 494%
peak of €85,681 in 2023
€60,100▲ 560%
€49,626▼ 22.2%
Board1 name since 2019
1 director
Documentsfilings and deeds
20-09-202641 days before the deadline
2026micro format
Gross margin from €17,906 to €85,877Result from €8,580 to €50,993Equity from €9,107 to €60,100Debts from €63,811 to €49,626Investments €23,766Cash from €40 to €5,224

Key points

from the 2026 annual accounts

Equity

€60,100 ▲ 560%
€9,1102025€60,1002026

Equity rose in 2026 from €9,107 to €60,100.

Investments

€23,766 1.8 times depreciation
20222023202420252026

Green is investment, beige is depreciation.

Liquidity

0.71 was 0.16 in 2025

Short-term debts fell from €56,811 to €49,626.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 26,977 companies had the same profile as EAS-MED has now. Each dot stands for 68 companies, two years later.

94.8%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 26,977 companies, not a prediction for EAS-MED. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 09-12-2019
  • 100 sharesdeed of 11-12-2019
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0738882454
Incorporation Founded by · 100 shares · appointed as director and managing director · published on 11-12-2019 · Gazette deed
First establishment EAS-MED SRL, Commandant Vander Meerenlaan 9, Anderlecht
All 12 events

Comparable companies

same main activity, similar in size and age
Company
EAS-MED Anderlecht €109,726 €85,877 54.8% -
Dr. Darcis Dermatology Brussels €100,949 €80,010 65.6% -
DOCTEUR JERRY COUSIN PEDIATRE Hoeilaart €113,503 €88,264 2.2% -
DR. E. VANDER STICHELE, GERIATER Ghent €108,726 €88,880 4.6% -
MY DERMA CONSULT Merchtem €110,790 €81,209 54.9% -
Uvea Tienen €110,165 €82,010 88.7% -
Dr. Iris Bombaert Leuven €129,500 €85,581 43.7% -

These companies have the same main activity as EAS-MED: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €101,000 and €129,000, founded between 2019 and 2020.

Official details

Source: KBO
Status
Active since 09-12-2019Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.299.877.1261070 Anderlecht, since 09-12-2019
Financial year end
31 March
Peppol
Reachable since 02-12-2025
Company details

Annual accounts to 31-03-2026

≈ €190,000estimated
€109,726▲ 50.5%
Filing
Filed on 20-09-2026, 41 days before the end of the filing period
Financials

Insights on EAS-MED

EAS-MED files the micro format. That format states no turnover. The gross margin fell from €87,805 in 2021 to €85,877 in 2026.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about EAS-MED

What is the company number of EAS-MED?
The company number of EAS-MED is 0738.882.454. The VAT number is the same number with BE in front: BE 0738.882.454.
Where is EAS-MED based?
The registered office is at Commandant Vander Meerenlaan 9, 1070 Anderlecht.Company details
What does EAS-MED do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of EAS-MED?
EAS-MED is a private limited company (BV).
When was EAS-MED founded?
EAS-MED was founded on 09-12-2019.
Is EAS-MED still active?
Yes, EAS-MED is an active enterprise in the KBO register.
What is the turnover of EAS-MED?
The turnover in financial year 2026 is ≈ €190,000. This figure is estimated from the gross margin of €85,877 and 33 comparable companies (NACE 862). It probably lies between €150,000 and €240,000.Financials
Is EAS-MED profitable?
In financial year 2026, EAS-MED made a profit of €50,993.
Where can I find the annual accounts of EAS-MED?
EAS-MED filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2026.
When are the next annual accounts of EAS-MED due?
EAS-MED must file the annual accounts for financial year 2027 by 31-10-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.